CVE-2018-16148 — The diagnosticsb2ksy parameter of the /rest endpoint in Opsview Monitor before 5

The diagnosticsb2ksy parameter of the /rest endpoint in Opsview Monitor before 5.3.1 and 5.4.x before 5.4.2 is vulnerable to Cross-Site Scripting.

01What is this vulnerability?

The diagnosticsb2ksy parameter of the /rest endpoint in Opsview Monitor before 5.3.1 and 5.4.x before 5.4.2 is vulnerable to Cross-Site Scripting.

02Affected products

Vendor	Product	Versions
n	a / n/a	n/a

03Active exploitation status

Not currently listed on the CISA Known Exploited Vulnerabilities (KEV) catalog. EPSS is the best forward-looking signal — see the EPSS row above.

04Recommended remediation

• Patch to a fixed version listed in the vendor advisory (see references below).
• Mitigate with WAF rules, network egress filters, or feature flags where the patch is not yet available.
• Hunt historical logs for exploitation indicators — see Detection signatures below.

05Technical details

For the full vendor write-up, exploit chains, and reference implementations, see the references list in section 09.

06Detection signatures

Ask SARA in chat to draft a starting detection for this CVE in your stack of choice.

07Related CVEs

No directly-cited follow-up CVEs in the KB record for this advisory. The references list in section 09 carries the vendor cross-references.

08Timeline

• Published: 2018-09-05T21:00:00.000Z
• Last modified: 2024-08-05T10:17:38.353Z

09References

• knowledge.opsview.com — https://knowledge.opsview.com/v5.4/docs/whats-new
• seclists.org — https://seclists.org/fulldisclosure/2018/Sep/3
• www.coresecurity.com — https://www.coresecurity.com/advisories/opsview-monitor-multiple-vulnerabilities
• knowledge.opsview.com — https://knowledge.opsview.com/v5.3/docs/whats-new